Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Alamar Biosciences, Inc. (ALMR : NSDQ)
 
 • Company Description   
Alamar Biosciences Inc. is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA(TM) technology and the ARGO(TM) HT System, the company's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. Alamar Biosciences Inc. is based in FREMONT, Calif.

Number of Employees: 222

 
 • Price / Volume Information   
Yesterday's Closing Price: $30.69 Daily Weekly Monthly
20 Day Moving Average: 772,442 shares
Shares Outstanding: 69.39 (millions)
Market Capitalization: $2,129.67 (millions)
Beta:
52 Week High: $39.61
52 Week Low: $18.85
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -7.56% -6.59%
12 Week 22.42% 19.43%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
47071 BAYSIDE PARKWAY
-
FREMONT,CA 94538
USA		 ph: 510-626-9888
fax: 510-605-5062		 investors@alamarbio.com https://alamarbio.com
 
 • General Corporate Information   
Officers
Yuling Luo - Chief Executive Officer and Chairman
Timothy Tod White - President
Shiping Steve Chen - Chief Operating Officer and Director
Justin McAnear - Chief Financial Officer
Rebecca Chambers - Director

Peer Information
Alamar Biosciences, Inc. (CORR.)
Alamar Biosciences, Inc. (RSPI)
Alamar Biosciences, Inc. (CGXP)
Alamar Biosciences, Inc. (BGEN)
Alamar Biosciences, Inc. (GTBP)
Alamar Biosciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 010911105
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/03/26
Share - Related Items
Shares Outstanding: 69.39
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $2,129.67 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.19 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.22 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.80
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 87.36%
Sales Growth
vs. Year Ago Period: 82.08%
vs. Previous Quarter: 13.03%
ROE
09/30/26 - -
06/30/26 - -
03/31/26 - -
ROA
09/30/26 - -
06/30/26 - -
03/31/26 - -
Current Ratio
09/30/26 - -
06/30/26 - 11.85
03/31/26 - 5.88
Quick Ratio
09/30/26 - -
06/30/26 - 10.23
03/31/26 - 4.22
Operating Margin
09/30/26 - -
06/30/26 - -
03/31/26 - -
Net Margin
09/30/26 - -
06/30/26 - -
03/31/26 - -
Pre-Tax Margin
09/30/26 - -
06/30/26 - -
03/31/26 - -
Book Value
09/30/26 - -
06/30/26 - 4.51
03/31/26 - -2.68
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - -
Debt-to-Equity
09/30/26 - -
06/30/26 - 0.03
03/31/26 - -
Debt-to-Capital
09/30/26 - -
06/30/26 - 3.08
03/31/26 - 56.84
 

Powered by Zacks Investment Research ©